Latest News and Press Releases
Want to stay updated on the latest news?
-
Dublin, June 12, 2025 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides and Customization" has been added...
-
Dublin, May 29, 2025 (GLOBE NEWSWIRE) -- The "Penicillin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" has been added to ResearchAndMarkets.com's offering. ...
-
Dublin, April 22, 2025 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Diagnostics Market, Global, 2024-2030" report has been added to ResearchAndMarkets.com's offering.This report examines the...
-
Dublin, April 09, 2025 (GLOBE NEWSWIRE) -- The "Peptide Antibiotics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2025-2034" report has been added to ...
-
Dublin, Dec. 31, 2024 (GLOBE NEWSWIRE) -- The "Antimicrobial Resistance Diagnostic Markets, Strategies and Trends by Pathogen and Technology, With Executive Guides and Customization 2023 to 2027"...
-
Dublin, Dec. 26, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Therapeutics Market 2025-2029 - Insights by Pathogen and Therapy Type, with Situation Analysis, Executive, and Investor Guides"...
-
Dublin, Oct. 15, 2024 (GLOBE NEWSWIRE) -- The "Antibiotic Resistance Markets - Therapeutics by Pathogen and Therapy Type. With Situation Analysis, Executive & Investor Guides &...
-
Paratek Pharmaceuticals Announces Presentation of Several New Studies of NUZYRA® (omadacycline) Across a Range of Serious Infections at IDWeek 2024
-
www.inbiome.com More precise diagnostics lead to quicker, more accurate patient treatment, saving lives and improving patient outcomesUS market introduction foreseen early 2026 ...
-
Paratek Pharmaceuticals Completes Five-Year Microbiologic Surveillance Study of NUZYRA® (omadacycline)